Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2018 | 01-2017 | 01-2016 | 01-2015 | 01-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 448 | 669 | 1,278 | 578 | 659 |
| Depreciation Amortization | 250 | 218 | 203 | 122 | 101 |
| Income taxes - deferred | 22 | 183 | -207 | N/A | N/A |
| Accounts receivable | -354 | -182 | 38 | -11 | -266 |
| Accounts payable and accrued liabilities | -43 | -68 | -7 | 109 | -147 |
| Other Working Capital | -431 | -542 | -392 | -12 | -111 |
| Other Operating Activity | 395 | 250 | 48 | -40 | 491 |
| Operating Cash Flow | $288 | $528 | $961 | $746 | $726 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17 | -540 | N/A | N/A | N/A |
| PPE Investments | -373 | -295 | -200 | -368 | -294 |
| Purchase Of Investment | N/A | N/A | N/A | -46 | -1 |
| Investing Cash Flow | $-390 | $-835 | $-200 | $-414 | $-295 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 453 |
| Debt Repayment | 106 | -76 | -186 | -18 | -415 |
| Common Stock Issued | 6 | 9 | 9 | 10 | N/A |
| Other Financing Activity | -24 | -24 | -26 | -32 | -30 |
| Financing Cash Flow | $88 | $-91 | $-202 | $-39 | $7 |
| Exchange Rate Effect | -7 | 109 | -107 | -162 | -83 |
| Beginning Cash Position | 653 | 943 | 491 | 360 | 4 |
| End Cash Position | 633 | 653 | 943 | 491 | 360 |
| Net Cash Flow | $-21 | $-289 | $451 | $132 | $355 |
| Free Cash Flow | |||||
| Operating Cash Flow | 288 | 528 | 961 | 746 | 726 |
| Capital Expenditure | -373 | -295 | -200 | -368 | -294 |
| Free Cash Flow | -85 | 233 | 761 | 379 | 432 |